Acumen Pharmaceuticals
ABOS
#8034
Rank
HK$1.50 B
Marketcap
HK$20.81
Share price
-16.93%
Change (1 day)
31.21%
Change (1 year)

Earnings for Acumen Pharmaceuticals (ABOS)

Earnings in 2024 (TTM): -HK$0.46 Billion

According to Acumen Pharmaceuticals's latest financial reports the company's current earnings are N/A. In 2023 the company made an earning of -HK$0.38 Billion a decrease over its 2022 earnings that were of -HK$0.36 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Acumen Pharmaceuticals from 2020 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -HK$0.46 Billion22.46%
2023 -HK$0.38 Billion6.32%
2022 -HK$0.36 Billion-173.58%
2021 HK$0.47 B-876.96%
2020 -HK$61.55 Million